| For: | Ballard BR, M’Koma AE. Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn’s colitis. World J Gastrointest Endosc 2015; 7(7): 670-674 [PMID: 26140094 DOI: 10.4253/wjge.v7.i7.670] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v7/i7/670.htm |
| Number | Citing Articles |
| 1 |
Jing Zhou, Jialing Liu, Yangyang Gao, Liwei Shen, Sheng Li, Simin Chen. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.707776
|
| 2 |
Tahira Riaz, Ludvig Magne Sollid, Ingrid Olsen, Gustavo Antonio de Souza. Quantitative Proteomics of Gut-Derived Th1 and Th1/Th17 Clones Reveal the Presence of CD28+ NKG2D- Th1 Cytotoxic CD4+ T cells. Molecular & Cellular Proteomics 2016; 15(3) doi: 10.1074/mcp.M115.050138
|
| 3 |
Melissa A. Fernandes, Sofia Verstraete, Melvin B. Heyman. Pediatric Inflammatory Bowel Disease. 2017; doi: 10.1007/978-3-319-49215-5_9
|
| 4 |
Amanda D. Williams, Olga Y. Korolkova, Amos M. Sakwe, Timothy M. Geiger, Samuel D. James, Roberta L. Muldoon, Alan J. Herline, J. Shawn Goodwin, Michael G. Izban, Mary K. Washington, Duane T. Smoot, Billy R. Ballard, Maria Gazouli, Amosy E. M'Koma, Shree Ram Singh. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLOS ONE 2017; 12(8) doi: 10.1371/journal.pone.0179710
|
| 5 |
Anet A. Soubières, Andrew Poullis. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2016; 22(8) doi: 10.1097/MIB.0000000000000836
|
| 6 |
Peng Chen, Gaoshi Zhou, Jingxia Lin, Li Li, Zhirong Zeng, Minhu Chen, Shenghong Zhang. Serum Biomarkers for Inflammatory Bowel Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00123
|
| 7 |
Amosy E. M’Koma. Secure Ileal Pouch–Anal Anastomosis for Histologic Indeterminate Colitis. Journal of Clinical Medicine 2025; 14(23) doi: 10.3390/jcm14238390
|